Deferoxamine
Showing 76 - 87 of 87
Sickle Cell Disease, Iron Overload, Hemolytic Anemia Trial in Canada, United States (Deferasirox (ICL670), Deferoxamine (DFO))
Completed
- Sickle Cell Disease
- +2 more
- Deferasirox (ICL670)
- Deferoxamine (DFO)
-
Birmingham, Alabama
- +58 more
May 23, 2011
Thalassemia Trial in New York (Deferoxamine, Deferasirox)
Unknown status
- Thalassemia
- Deferoxamine
- Deferasirox
-
New York, New YorkWeill Cornell Medical Center
Nov 4, 2010
Transfusional Iron Overload in ß-thalassemia Trial in Worldwide (Deferasirox)
Completed
- Transfusional Iron Overload in β-thalassemia
-
Los Angeles, California
- +48 more
May 24, 2011
Iron Overload, Thalassemia Trial in New York (Combination Iron Chelation Therapy)
Completed
- Iron Overload
- Thalassemia
- Combination Iron Chelation Therapy
-
New York, New YorkCornell University Medical College
Jan 12, 2010
Iron Overload, Cardiomyopathy Trial in Cagliari (Deferoxamine and Deferiprone, Deferoxamine)
Completed
- Iron Overload
- Cardiomyopathy
- Deferoxamine and Deferiprone
- Deferoxamine
-
Cagliari, Sardinia, ItalyAdult Talassemic Center, Ospedale Microcitemico
Dec 1, 2008
Beta-Thalassemia, Thalassemia Major Trial in Palermo (Deferiprone (DFP) and Deferoxamine (DFO), Deferiprone (DFP))
Completed
- Beta-Thalassemia
- Thalassemia Major
- Deferiprone (DFP) and Deferoxamine (DFO)
- Deferiprone (DFP)
-
Palermo, ItalyAo V. Cervello
Aug 12, 2008
Beta Thalassemia Trial run by the NIDDK (5-Azacytidine)
Completed
- Beta Thalassemia
-
Bethesda, MarylandNational Institute of Diabetes and Digestive and Kidney Diseases
Mar 3, 2008
Beta Thalassemia, Hemoglobinopathy Trial run by the NIDDK (Hydroxyurea)
Completed
- Beta Thalassemia
- Hemoglobinopathy
-
Bethesda, MarylandNational Institute of Diabetes and Digestive and Kidney Diseases
Mar 3, 2008
Beta-Thalassemia Trial in Cagliari (deferiprone)
Unknown status
- Beta-Thalassemia
-
Cagliari, Sardinia, ItalyOspedale Microcitemico, Via Jenner
Jun 23, 2005